Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 1
2017 1
2018 2
2019 1
2020 2
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma.
Coccè V, Bonelli M, La Monica S, Alfieri R, Doneda L, Martegani E, Alessandri G, Lagrasta CA, Giannì A, Sordi V, Petrella F, Roncoroni L, Paino F, Pessina A. Coccè V, et al. Among authors: lagrasta ca. Biochem Pharmacol. 2023 Aug;214:115678. doi: 10.1016/j.bcp.2023.115678. Epub 2023 Jul 1. Biochem Pharmacol. 2023. PMID: 37399948 Free article.
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors.
Urbanek K, Frati C, Graiani G, Madeddu D, Falco A, Cavalli S, Lorusso B, Gervasi A, Prezioso L, Savi M, Ferraro F, Galaverna F, Rossetti P, Lagrasta CA, Re F, Quaini E, Rossi F, Angelis AD, Quaini F. Urbanek K, et al. Among authors: lagrasta ca. Curr Drug Targets. 2015;16(8):884-94. doi: 10.2174/1389450116666150126105002. Curr Drug Targets. 2015. PMID: 25619752 Review.
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells.
Coccè V, La Monica S, Bonelli M, Alessandri G, Alfieri R, Lagrasta CA, Madeddu D, Frati C, Flammini L, Lisini D, Marcianti A, Parati E, Paino F, Giannì A, Farronato G, Falco A, Spaggiari L, Petrella F, Pessina A. Coccè V, et al. Among authors: lagrasta ca. Cells. 2021 Jun 8;10(6):1427. doi: 10.3390/cells10061427. Cells. 2021. PMID: 34201002 Free PMC article.
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice.
La Monica S, Coccé V, Bonelli M, Alessandri G, Alfieri R, Lagrasta CA, Frati C, Flammini L, Gianni A, Petrella F, Paino F, Pessina A. La Monica S, et al. Among authors: lagrasta ca. Curr Cancer Drug Targets. 2023;23(8):663-668. doi: 10.2174/1568009623666230201092302. Curr Cancer Drug Targets. 2023. PMID: 36722476 Free article.
Low PD-1 Expression in Cytotoxic CD8+ Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value.
Mazzaschi G, Madeddu D, Falco A, Bocchialini G, Goldoni M, Sogni F, Armani G, Lagrasta CA, Lorusso B, Mangiaracina C, Vilella R, Frati C, Alfieri R, Ampollini L, Veneziani M, Silini EM, Ardizzoni A, Urbanek K, Aversa F, Quaini F, Tiseo M. Mazzaschi G, et al. Among authors: lagrasta ca. Clin Cancer Res. 2018 Jan 15;24(2):407-419. doi: 10.1158/1078-0432.CCR-17-2156. Epub 2017 Oct 26. Clin Cancer Res. 2018. PMID: 29074606
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells†.
Ampollini L, Madeddu D, Falco A, Frati C, Lorusso B, Graiani G, Saccani F, Gervasi A, Rossetti P, Bonomini S, Gnetti L, Lagrasta CA, Silini EM, Quaini E, Petronini P, Alfieri R, Rusca M, Carbognani P, Quaini F. Ampollini L, et al. Among authors: lagrasta ca. Eur J Cardiothorac Surg. 2014 Dec;46(6):e103-12. doi: 10.1093/ejcts/ezu359. Epub 2014 Oct 13. Eur J Cardiothorac Surg. 2014. PMID: 25312525
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer.
Armani G, Madeddu D, Mazzaschi G, Bocchialini G, Sogni F, Frati C, Lorusso B, Falco A, Lagrasta CA, Cavalli S, Mangiaracina C, Vilella R, Becchi G, Gnetti L, Corradini E, Quaini E, Urbanek K, Goldoni M, Carbognani P, Ampollini L, Quaini F. Armani G, et al. Among authors: lagrasta ca. Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1205-1213. doi: 10.1093/ejcts/ezx492. Eur J Cardiothorac Surg. 2018. PMID: 29346540
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations.
Bonelli MA, Cavazzoni A, Saccani F, Alfieri RR, Quaini F, La Monica S, Galetti M, Cretella D, Caffarra C, Madeddu D, Frati C, Lagrasta CA, Falco A, Rossetti P, Fumarola C, Tiseo M, Petronini PG, Ardizzoni A. Bonelli MA, et al. Among authors: lagrasta ca. Mol Cancer Ther. 2015 Aug;14(8):1916-27. doi: 10.1158/1535-7163.MCT-14-0892. Epub 2015 May 26. Mol Cancer Ther. 2015. PMID: 26013318
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC.
La Monica S, Minari R, Cretella D, Flammini L, Fumarola C, Bonelli M, Cavazzoni A, Digiacomo G, Galetti M, Madeddu D, Falco A, Lagrasta CA, Squadrilli A, Barocelli E, Romanel A, Quaini F, Petronini PG, Tiseo M, Alfieri R. La Monica S, et al. Among authors: lagrasta ca. J Exp Clin Cancer Res. 2019 May 28;38(1):222. doi: 10.1186/s13046-019-1240-x. J Exp Clin Cancer Res. 2019. PMID: 31138260 Free PMC article.
12 results